Inhibitory effect of trichostatin on allograft rejection of corneal transplantation in rats.

IF 0.2 Q4 MEDICINE, RESEARCH & EXPERIMENTAL
International journal of clinical and experimental medicine Pub Date : 2015-08-15 eCollection Date: 2015-01-01
Reziwan Maimaitiming, Xin Yang, Kelala Wupuer, Nan Ye, Zhiqiang Pan
{"title":"Inhibitory effect of trichostatin on allograft rejection of corneal transplantation in rats.","authors":"Reziwan Maimaitiming, Xin Yang, Kelala Wupuer, Nan Ye, Zhiqiang Pan","doi":"","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Using a rat penetrating keratoplasty model, this study aims to explore the inhibitory effect of hachimycin on corneal graft rejection, to provide new basis for its clinical application.</p><p><strong>Materials and methods: </strong>Female adult Sprague-Dawley (SD) rats weighing between 220-250 g were used as acceptors and male or female Wistar rats weighing between 220-250 g were used as donors. The rats with a successful keratoplasty were randomly divided into 3 groups with 10 rats in each group. Group A: penetrating keratoplasty group; Group B: penetrating keratoplasty followed by the application of control eye drops containing eye drops matrix dissolved in 20 g/L DMSO and 900 mL/L artificial tear; Group C: penetrating keratoplasty followed by the application of 0.5 g/L hachimycin eye drops. Hachimycin was dissolved in vitamin E to obtain an eye solution with a pH value of 6~7, and stored at 4°C. The local application of hachimycin eye drops started 5 days after the keratoplasty surgery, 5 times per day until the onset of rejection response. At 4 days after the keratoplasty surgery, slit-lamp microscope was used to observe the transplanted cornea once every two days, and a rejection index (RI) of 0-12 was obtained according to the three graft components represented by corneal transparency, edema, and corneal neovascularization.</p><p><strong>Results: </strong>Penetrating keratoplasty was successfully performed on all the 3 groups of rats. Five days after the keratoplasty, both the transparency and the implant edema showed a score of 1-2 degrees in group A and B. Two weeks later, both these two grafts components increased to a score of 2-3 degrees in group A and B, with an active neovascularization. The group C also showed a transparency and implant edema of 1-2 degrees five days after the keratoplasty surgery. However, a transparent implant without edema was observed in group C two weeks after the keratoplasty surgery. In addition, the newly formed blood vessels disappeared and the retina appeared in a good status and in the correct position. The corneal transparency, edema, corneal neovascularization, and total RI scores of the 3 groups clearly indicated that the group B showed an improvement compared to the group A (P < 0.05), since in group B the new vessels were only distributed in the corneal limbus at five days after the surgery. However, at two weeks after the surgery no statistically significant difference in neovascularization degree was observed in group B when compared with group A, while a statistically significant decrease of neovascularization was observed in group C (P < 0.05).</p><p><strong>Conclusions: </strong>Hachimycin may inhibit the rejection responses after penetrating keratoplasty by the reduction of corneal edema, transparency and neovascularization.</p>","PeriodicalId":13892,"journal":{"name":"International journal of clinical and experimental medicine","volume":"8 8","pages":"12424-9"},"PeriodicalIF":0.2000,"publicationDate":"2015-08-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4612839/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"International journal of clinical and experimental medicine","FirstCategoryId":"1085","ListUrlMain":"","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2015/1/1 0:00:00","PubModel":"eCollection","JCR":"Q4","JCRName":"MEDICINE, RESEARCH & EXPERIMENTAL","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Using a rat penetrating keratoplasty model, this study aims to explore the inhibitory effect of hachimycin on corneal graft rejection, to provide new basis for its clinical application.

Materials and methods: Female adult Sprague-Dawley (SD) rats weighing between 220-250 g were used as acceptors and male or female Wistar rats weighing between 220-250 g were used as donors. The rats with a successful keratoplasty were randomly divided into 3 groups with 10 rats in each group. Group A: penetrating keratoplasty group; Group B: penetrating keratoplasty followed by the application of control eye drops containing eye drops matrix dissolved in 20 g/L DMSO and 900 mL/L artificial tear; Group C: penetrating keratoplasty followed by the application of 0.5 g/L hachimycin eye drops. Hachimycin was dissolved in vitamin E to obtain an eye solution with a pH value of 6~7, and stored at 4°C. The local application of hachimycin eye drops started 5 days after the keratoplasty surgery, 5 times per day until the onset of rejection response. At 4 days after the keratoplasty surgery, slit-lamp microscope was used to observe the transplanted cornea once every two days, and a rejection index (RI) of 0-12 was obtained according to the three graft components represented by corneal transparency, edema, and corneal neovascularization.

Results: Penetrating keratoplasty was successfully performed on all the 3 groups of rats. Five days after the keratoplasty, both the transparency and the implant edema showed a score of 1-2 degrees in group A and B. Two weeks later, both these two grafts components increased to a score of 2-3 degrees in group A and B, with an active neovascularization. The group C also showed a transparency and implant edema of 1-2 degrees five days after the keratoplasty surgery. However, a transparent implant without edema was observed in group C two weeks after the keratoplasty surgery. In addition, the newly formed blood vessels disappeared and the retina appeared in a good status and in the correct position. The corneal transparency, edema, corneal neovascularization, and total RI scores of the 3 groups clearly indicated that the group B showed an improvement compared to the group A (P < 0.05), since in group B the new vessels were only distributed in the corneal limbus at five days after the surgery. However, at two weeks after the surgery no statistically significant difference in neovascularization degree was observed in group B when compared with group A, while a statistically significant decrease of neovascularization was observed in group C (P < 0.05).

Conclusions: Hachimycin may inhibit the rejection responses after penetrating keratoplasty by the reduction of corneal edema, transparency and neovascularization.

曲司他丁对大鼠角膜移植异体排斥反应的抑制作用
背景:本研究旨在利用大鼠穿透性角膜移植术模型,探讨哈奇霉素对角膜移植排斥反应的抑制作用,为其临床应用提供新的依据:以体重在 220-250 g 之间的雌性成年 Sprague-Dawley (SD) 大鼠为受体,以体重在 220-250 g 之间的雄性或雌性 Wistar 大鼠为供体。将角膜移植手术成功的大鼠随机分为 3 组,每组 10 只。A 组:穿透性角膜移植术组;B 组:穿透性角膜移植术后滴入含有溶于 20 g/L DMSO 的滴眼液基质和 900 mL/L 人工泪液的对照滴眼液组;C 组:穿透性角膜移植术后滴入 0.5 g/L 的哈奇霉素滴眼液组。将哈奇霉素溶于维生素 E,得到 pH 值为 6~7 的眼液,并在 4°C 下保存。角膜移植手术后 5 天开始局部滴用哈奇霉素眼药水,每天 5 次,直至出现排斥反应。角膜移植手术后4天,使用裂隙灯显微镜观察移植角膜,每两天一次,根据角膜透明度、水肿和角膜新生血管所代表的三种移植成分,得出0-12的排斥指数(RI):结果:三组大鼠均成功实施了穿透性角膜移植术。角膜移植术五天后,A 组和 B 组大鼠的透明度和植入水肿均为 1-2 度,两周后,A 组和 B 组大鼠的透明度和植入水肿均增至 2-3 度,新生血管活跃。C 组在角膜移植手术五天后也显示出透明度和 1-2 度的植入水肿。但在角膜移植手术两周后,C 组的植入物透明且无水肿。此外,新生血管消失,视网膜状态良好,位置正确。三组的角膜透明度、水肿、角膜新生血管和 RI 总分清楚地表明,与 A 组相比,B 组的情况有所改善(P < 0.05),因为 B 组在术后五天时,新生血管仅分布在角膜缘。然而,在术后两周,B 组的新生血管程度与 A 组相比没有统计学意义上的差异,而 C 组的新生血管显著减少(P < 0.05):结论:通过减轻角膜水肿、透明度和新生血管,哈奇霉素可抑制穿透性角膜移植术后的排斥反应。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
期刊介绍: Information not localized
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信